latest news releases from the newsroom
Crucell Signs PER.C6 Antibody Production Agreement with Centocor
LEIDEN, The Netherlands, Jan. 16, 2003 (PRIMEZONE) -- Dutch antibody and vaccine company Crucell N.V. (Nasdaq:CRXL) today announced that it has signed a PER.C6(TM) research license agreement with Centocor Inc., a Johnson and Johnson company, allowing Centocor to evaluate the production of monoclonal antibodies using the PER.C6(TM) human cell line. Centocor also has an option for a non-exclusive, worldwide commercial product license to manufacture one or more specified monoclonal antibody products using the PER.C6(TM) cell line.
Chitwood & Harley
January 21, 2003 Is Deadline to File Lead Plaintiff Papers, Chitwood & Harley Informs Investors in Securities Fraud Class Action Lawsuit Against Sepracor, Inc. --SEPR
ATLANTA, Jan. 15, 2003 (PRIMEZONE) -- Chitwood & Harley announces that it has filed a class action lawsuit in the United States District Court for the District of Massachusetts, on behalf of purchasers of the common stock of Sepracor, Inc. (Nasdaq:SEPR) between May 17, 1999 and March 6, 2002 (the "Class Period"), against defendants Sepracor, Inc. ("SEPR") and certain of its officers and directors. The deadline to file lead plaintiff papers, for those class members wishing to serve in this capacity, is January 21, 2003, NOT January 19, 2003 or January 20, 2003 as many press releases concerning the class action lawsuits against SEPR have announced. The deadline moves to January 21, 2003 under the Federal Rules of Civil Procedure because January 19, 2003, the original deadline, falls on a Sunday and because January 20, 2003 is the anniversary of Martin Luther King Jr.'s birthday, which is a federal court holiday.